Genmab A (GMAB) Short-term Investments: 2018-2020
Historic Short-term Investments for Genmab A (GMAB) over the last 3 years, with Dec 2020 value amounting to -$1.4 billion.
- Genmab A's Short-term Investments fell 183.50% to -$879.9 million in Q2 2021 from the same period last year, while for Jun 2021 it was -$879.9 million, marking a year-over-year decrease of 183.50%. This contributed to the annual value of -$1.4 billion for FY2020, which is 138.60% down from last year.
- Latest data reveals that Genmab A reported Short-term Investments of -$1.4 billion as of FY2020, which was down 138.60% from -$604.4 million recorded in FY2019.
- In the past 5 years, Genmab A's Short-term Investments registered a high of -$389.3 million during FY2018, and its lowest value of -$1.4 billion during FY2020.
- In the last 3 years, Genmab A's Short-term Investments had a median value of -$604.4 million in 2019 and averaged -$811.9 million.
- Data for Genmab A's Short-term Investments shows a maximum YoY tumbled of 138.60% (in 2020) over the last 5 years.
- Over the past 3 years, Genmab A's Short-term Investments (Yearly) stood at -$389.3 million in 2018, then slumped by 55.26% to -$604.4 million in 2019, then tumbled by 138.60% to -$1.4 billion in 2020.